71st NSRS Conference Abstract

Background: Downsizing tumor in readiness for surgical extirpation is the tradition aim of neoadjuvant chemotherapy (NAC) for locally advanced breast cancer (LABC). This is still the prevalent target clinical endpoint (TCE) for NAC in Nigeria because of florid grave signs. Numerous criteria such as response evaluation criteria in solid tumors (RECIST) and progression-free survival measure NAC effect while realization of readiness for surgical extirpation are under-reported